You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

45 Results
Guidelines and Advice
Status: Current
ID: GL1-10
Version: 4
Mar 2024
Guidelines and Advice
Mar 2024
Guidelines and Advice
Drug
Other Name(s): Revlimid®
Mar 2024
Regimen
Intent: Adjuvant
Oct 2017
Regimen
Intent: Adjuvant
Oct 2017
Regimen
Intent: Adjuvant
Oct 2017
Regimen
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Oct 2017
Regimen
Cancer Type:
Gynecologic, 
Endometrial
Intent: Palliative
Funding:
ODB - General Benefit
  • megestrol - oral tablets
Oct 2017

Pages